SCHEMBL29357674

SCHEMBL29357674

c1cc(-c2ccc3c(c2)c2ccccc2n3-c2cccc(-n3c4ccccc4c4cc(-c5cccc(-n6c7ccccc7c7ccccc76)c5)ccc43)c2)cc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ ATM Q13315 2/20 0.53
▸ TSPO P30536 3/20 0.40
▸ KMT2A Q03164 5/20 0.37
▸ IL1R1 P14778 1/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ HTT P42858 4/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ FAAH O00519 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ MGLL Q99685 1/20 0.36
▸ PTGER4 P35408 1/20 0.35
▸ NPY5R Q15761 2/20 0.35
▸ EDNRB P24530 1/20 0.35
▸ EDNRA P25101 1/20 0.35
▸ HPGD P15428 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23341615 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL12231985 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL31620131 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL15435802 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL10042920 1.00 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL15435791 0.97 ATM (0.55) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL15435808 0.97 ATM (0.55) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL12113746 0.96 L3MBTL1 (0.53) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL18352325 0.96 KDM4E (0.57) L3MBTL1KDM4EATMTSPOKMT2A
SCHEMBL23838458 0.95 L3MBTL1 (0.48) L3MBTL1KDM4EATMTSPOKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 855 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12612638-B2 Fusion constructs to express biopharmaceutical polypeptides in cyanobacteria THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-04-28 — — US claimed
US-12391950-B2 Fusion constructs as protein over-expression vectors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-08-19 — — US claimed
CN-119885890-A Power system inertia time constant estimation method based on improved long-term and short-term memory network model 广东工业大学 2025-04-25 — — CN claimed
CN-119762161-A ASA advertisement keyword and material generation system based on AI 北京阳光伟烨网络技术有限公司 2025-04-04 — — CN claimed
CN-119161460-A Whole-cell biosensor and preparation method and application thereof 南京林业大学 2024-12-20 — — CN claimed
US-20240376174-A1 Heterohexameric Fusion Constructs for Protein Expression in Cyanobacteria THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2024-11-14 — — US claimed
CN-118772072-A Production process of prothioconazole 甘肃兰沃科技有限公司 2024-10-15 — — CN claimed
EP-4396328-A2 HETEROHEXAMERIC FUSION CONSTRUCTS FOR PROTEIN EXPRESSION IN CYANOBACTERIA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-07-10 — — EP claimed
US-20240150775-A1 FUSION CONSTRUCTS AS PROTEIN OVER-EXPRESSION VECTORS US DEPARTMENT OF ENERGY 2024-05-09 — — US claimed
CN-220446530-U Shaver 佛山市顺德区雷泰电器制造有限公司 2024-02-06 — — CN claimed
WO-2023035334-A1 METHOD FOR QUANTITATIVELY MEASURING PHYCOCYANIN AND SPECIAL STANDARD PRODUCT THEREFOR 上海城市水资源开发利用国家工程中心有限公司 2023-03-16 — — WO claimed
WO-2023034960-A2 HETEROHEXAMERIC FUSION CONSTRUCTS FOR PROTEIN EXPRESSION IN CYANOBACTERIA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-03-09 — — WO claimed
US-20220372499-A1 FUSION CONSTRUCTS TO EXPRESS BIOPHARMACEUTICAL POLYPEPTIDES IN CYANOBACTERIA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2022-11-24 — — US claimed
CN-114958892-A Method for producing phycocyanin by expression in bacteria 南京林业大学 2022-08-30 — — CN claimed
EP-4028529-A1 FUSION CONSTRUCTS TO EXPRESS BIOPHARMACEUTICAL POLYPEPTIDES IN CYANOBACTERIA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-07-20 — — EP claimed
US-20220135627-A1 THERMOSTABLE PHYCOBILIPROTEINS PRODUCED FROM RECOMBINANT ARTHROSPIRA Lumen Bioscience, Inc. 2022-05-05 — — US claimed
US-20260150501-A1 DISPLAY APPARATUS LG DISPLAY CO., LTD. (KR) 2026-05-28 — — US disclosed
US-20260148700-A1 Display Device and Display Driving Method LG DISPLAY CO., LTD. (KR) 2026-05-28 — — US disclosed
US-20220025446-A1 METHODS OF USING MASTER / COPY ARRAYS FOR SPATIAL DETECTION 10X GENOMICS, INC. (US) 2022-01-27 — — US disclosed
EP-3943492-A1 TADF MATERIALS COMPRISING 4-(3-(2-(10H-PHENOXAZIN-10-YL)PYRIDIN-5-YL)-9H-CARBAZOL-9-YL)BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN OLEDS Noctiluca S.A. (PL) 2022-01-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612638-B2 Fusion constructs to express biopharmaceutical polypeptides in cyanobacteria CPB2, IRF2BP2, SPPL2B L3MBTL1 3310/4885KDM4E 4641/4885ATM 533/4885
US-20260148700-A1 Display Device and Display Driving Method TRPM8, TRPM4, TRPM2 L3MBTL1 3107/4885KDM4E 1275/4885ATM 1089/4885
US-20260150501-A1 DISPLAY APPARATUS L1CAM, LATS2, TMED2 L3MBTL1 1137/4885KDM4E 1200/4885ATM 2290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback